Synergy CHC Corp. (SNYR)
NASDAQ: SNYR · Real-Time Price · USD
5.82
-0.08 (-1.36%)
Nov 20, 2024, 4:00 PM EST - Market closed
Synergy CHC Revenue
Synergy CHC had revenue of $8.02M in the quarter ending June 30, 2024, a decrease of -25.64%. This brings the company's revenue in the last twelve months to $41.46M, down -11.09% year-over-year. In the year 2023, Synergy CHC had annual revenue of $42.78M with 11.37% growth.
Revenue (ttm)
$41.46M
Revenue Growth
-11.09%
P/S Ratio
1.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
50.66M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OptiNose | 75.67M |
Precision BioSciences | 75.10M |
Cytosorbents | 37.74M |
BGM Group | 29.87M |
Kronos Bio | 9.87M |
Lucid Diagnostics | 4.19M |
vTv Therapeutics | 1.00M |
SNYR News
- 26 days ago - U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
- 27 days ago - Synergy CHC Corp. Announces Closing of Initial Public Offering - GlobeNewsWire
- 4 weeks ago - Synergy CHC Corp. Prices $10.35 Million Initial Public Offering - GlobeNewsWire
- 2 years ago - Synergy CHC Pursues $69 Million U.S. Uplisting IPO - Seeking Alpha